Targeted Therapies

Targeted Therapies

Turning stories of heartbreak into stories of hope.

Learn More

Survivor Wine

Survivor Wine

Surviving cancer is always a cause for celebration

Learn More

Jeff Wigbels

Jeff Wigbels

Take Aim at Cancer Founder Jeff Wigbels

Learn More

News and Events

News and Events

Learn more about upcoming Take Aim at Cancer events.

Learn More

Your Donation Supports Cutting-Edge Research

Your Donation Supports Cutting-Edge Research

Your donation will have an immediate impact on the fight against cancer.

Learn More

On October 11, 2006, Jeff Wigbels learned he had Stage IV non-smokers lung cancer. The next day, his wife — unaware of this — gave birth to their son. The following day, Jeff told her there was a good chance their son soon might not have a dad. But today, because of funding for research into targeted therapies, Jeff is watching his children grow up. He believes he’s been given a gift, one that he and Tiffany want to give back, and Take Aim at Cancer was born.

In 2013, Take Aim at Cancer merged with LUNGevity Foundation, the nation’s largest private funder of lung cancer research, to continue the efforts to fund impactful research into targeted therapies and early detection of lung cancer.

Donate now to support targeted-therapy cancer research and treatment.

Survivor Wine - Prepare to toast to your health.

Researching and advancing molecular-level cancer therapy for promising results.

LUNGevity YouTube LUNGevity Facebook LUNGevity Twitter